Advertisement

Topics

WuXi’s Pharmaceutical Development Services Division, STA merge

15:26 EDT 1 Aug 2017 | CentreWatch

STA Pharmaceutical, a WuXi AppTec group company and an open-access capability and technology platform for small molecule pharmaceutical development and manufacturing—announces that it has merged with WuXi AppTec’s Pharmaceutical Development Services (PDS) division. The PDS division offers pre-formulation development, formulation development, as well as Clinical Trial Material (CTM) manufacturing, packaging and labeling of oral solid […]

The post WuXi’s Pharmaceutical Development Services Division, STA merge appeared first on CenterWatch News Online.

Original Article: WuXi’s Pharmaceutical Development Services Division, STA merge

NEXT ARTICLE

More From BioPortfolio on "WuXi’s Pharmaceutical Development Services Division, STA merge"

Quick Search
Advertisement
 

Relevant Topic

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...